Wall Street Manna
An irreverent look at Wall Street
Wednesday, December 9, 2009
Vanda Pharamceuticals upgraded
Jeffries touted VNDA today, with a target of 22.
Yesterday $200 million went to VNDA from Novartis for commercialization rights to Fanapt (TM), VNDA's schizophrenia drug.
It should get a tradeable rally here.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)